Clinical Trials Logo

Burns clinical trials

View clinical trials related to Burns.

Filter by:

NCT ID: NCT00540566 Completed - Burns Clinical Trials

Optical Biopsy of Human Skin in Conjunction With Laser Treatment

Start date: June 1999
Phase:
Study type: Observational

This study is to compare the ability of optical biopsy. Research can use light enters the skin, collected, analyzed by the computer, and a picture created for the pathologist to conventional histologic examination compare with the pathologist looking at the piece of tissue through a microscope makes the diagnosis.

NCT ID: NCT00539110 Completed - Sleep Clinical Trials

Differential Effects of Zolpidem Versus Ramelteon in Burned Children

Sleep3
Start date: December 2009
Phase: Phase 2
Study type: Interventional

To examine sleep changes following therapeutic drug interventions designed to promote sleep.

NCT ID: NCT00536276 Completed - Burns Clinical Trials

Evaluation of Vitamin D Status in Children With Acute Burns

VitaminD
Start date: March 2003
Phase: Phase 1
Study type: Interventional

To see which vitamin D supplement (D2 vs D3) is most beneficial in burned children.

NCT ID: NCT00471939 Completed - Burns Clinical Trials

Safety and Efficacy of I-020502 in Meshed Skin Autografting

Start date: April 2007
Phase: Phase 2
Study type: Interventional

This is a phase II, multi-centre, controlled study comparing the safety and tolerability on wound healing following an application of I-020502 in a concentration of 1μg/mL TG-PDGF.AB versus staples applied in the same patient to burn areas requiring autologous meshed skin grafting.

NCT ID: NCT00467532 Completed - Burns Clinical Trials

Effect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Burned Patients

Start date: March 2007
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the effect of burn injury on the human immune system with a focus on cytomegalovirus (CMV) reactivation and the immunologic correlates of latent viral reactivation. Subjects will be patients admitted to the North Carolina Jaycee Burn Center with burn injury. Blood samples will be collected over time and will be evaluated for CMV reactivation and immune cell phenotype.

NCT ID: NCT00387543 Completed - Burning Sore Mouth Clinical Trials

Alpha Lipoic Acid for Burning Mouth

Start date: January 2000
Phase: N/A
Study type: Observational

Discussion and evaluation of patients with sore and burning mouth to determine whether alpha lipoic acid is helpful in managing their symptoms.

NCT ID: NCT00363558 Completed - Burn Clinical Trials

Fixation of Skin Grafts in Patients With Burns: Comparison Between Cyanoacrylate Glue and Skin Staples

Start date: January 2002
Phase: N/A
Study type: Observational

Skin graft fixation is essential for the success of its survival. There are several common methods for skin graft fixation including sutures, skin staples and glue. The study objective is to compare between skin graft fixation with staples and glue in burn patients. The study is retrospective. It Includes 44 patients that were hospitalized in the burn unit, Rabin Medical Center, Israel with 2nd and 3rd degree burns, total body surface area 1-50% during 1/2002-5/2003.All patients were operated for debridement and skin grafting. In 29 patients the skin graft was fixated with staples and in 15 with cyanoacrylate glue (histoacryl). The parameters that will be compared are skin graft take, hospitalization length and local infection.

NCT ID: NCT00361751 Completed - Insulin Resistance Clinical Trials

Substrate Cycling in Energy Metabolism

Start date: May 2003
Phase: Phase 2
Study type: Interventional

Insulin resistance and hyperglycemia contribute to negative outcomes in burned patients. We will assess insulin sensitivity in traditional terms of glucose metabolism, and with regard to the responsiveness of both muscle and liver protein metabolism, in severely burned patients. Plasma free fatty acid (FFA) and tissue TG levels will be manipulated via inhibition of peripheral lipolysis with nicotinic acid or activation of plasma lipoprotein lipase activity with heparin, stimulation of tissue fatty acid oxidation and thus reduction of tissue TG with the peroxisome proliferate-activated receptor (PPAR) alpha agonist fenofibrate. Methodological approaches will include stable isotope tracer techniques to quantify kinetic responses of protein, glucose and lipid metabolism in vivo, quantification of intracellular stores of TG and glycogen by means of magnetic resonance spectroscopy (MRS), as well as quantitative analysis of tissue levels of active products of fatty acids, key intermediates of the insulin signaling pathway, glycogen, the enzyme activities of citrate synthase and glycogen synthase and the activity of the muscle mitochondria. These studies will clarify the physiological and clinical significance of the alterations of tissue lipid metabolism that occur after burn injury, thereby forming the basis for new therapeutic approaches not only in this specific clinical condition but in other clinical circumstances in which hepatic and/or muscle TG is elevated. We will investigate the general hypothesis that the accumulation of intracellular TG in liver and muscle either directly causes insulin resistance in those tissues or serves as an indictor of the intracellular accumulation of active fatty acid products, such as fatty acyl CoA and diacylglycerol, which in turn disrupt insulin action. The following specific hypotheses will be investigated: 1. Intracellular TG is elevated in both muscle and liver in severely burned patients. The reduction of the fat in the liver and the insulin resistance will improve clinical outcomes, glucose and protein metabolism. 2. The insulin signaling pathway, as reflected by phosphoinositol-3-kinase (PI3K) and PKC activity, is impaired in tissues with elevated TG. 3. Fatty acids, or their active intracellular products, are the direct inhibitors of insulin action, rather than the tissue TG itself.

NCT ID: NCT00343824 Completed - Clinical trials for Burn Wounds - Partial Thickness (2nd Degree)

Bacterial Control in Partial Thickness Burns Using Silver-containing Wound Dressings

Start date: November 1, 2006
Phase: N/A
Study type: Interventional

This study is to compare the treatment with two different silver-containing wound dressings: aquacel AG hydrofiber versus acticoat burn dressing.

NCT ID: NCT00329654 Completed - Burns Clinical Trials

James EMBAR® Light Therapy in the Treatment of Burn Wounds of Intermediate Depth

Start date: March 2006
Phase: N/A
Study type: Interventional

This will be a prospective, randomized, single blinded, controlled study in a single center setting to assess the effect of either phototherapy with the Embar® light therapy or sham irradiation.